Together, these data confirm a critical role of PRMT1 activity for the initiation and progression of neuroblastoma tumor in a well-established preclinical mouse model and suggest that inhibition of PRMT1 activity may represent a promising strategy for neuroblastoma. The gene discussed is PRMT1; the disease is neoplasm.